Merrimack Pharmaceuticals Announces Changes to Board of Directors

Merrimack Pharmaceuticals (Nasdaq:MACK) (the Company or Merrimack) announced today that, effective immediately, its Board of Directors has appointed Noah G. Levy, of Newtyn Management, LLC (Newtyn) and Eric D. Andersen, of Western Standard, LLC (Western) to the Board, pursuant to a cooperation agreement.